Klotho Signaling

Alpha-Klotho was found by accident. Makoto Kuro-o and Yo-ichi Nabeshima reported in Nature in november 1997 that mice with disrupted klotho expression develop a syndrome resembling human aging: short lifespan, infertility, arteriosclerosis, skin atrophy, osteoporosis and emphysema [1]. The gene encodes a membrane protein with sequence similarity to beta-glucosidase enzymes, and the authors proposed it works as part of a signalling pathway regulating aging in vivo [1].

Membrane-bound Klotho forms co-receptor complexes with FGFR1c, FGFR3c and FGFR4, which is what lets those receptors bind FGF23 and control phosphate handling [4]. A cleaved soluble form circulates in blood and acts more broadly. Aditya Hajare and colleagues report that excess Klotho production rescued mice from kidney disease and extended their lifespan by roughly 30% [4]. In a cross-sectional cohort of 346 healthy people aged 18 to 85, serum Klotho correlated negatively with age, with the lowest levels in the 55 to 85 group [4].

The human mortality signal is consistent in direction but modest in size. Richard Semba and Luigi Ferrucci followed 804 InCHIANTI participants aged 65 and older for 6 years; 194 died, 24.1%. People in the lowest plasma Klotho tertile, below 575 pg/mL, had a hazard ratio for death of 1.78 (95% CI 1.20-2.63) against the highest tertile above 763 pg/mL, adjusted for age, sex, BMI, cholesterol, 25-hydroxyvitamin D, parathyroid hormone and chronic disease [2]. Jacob Kresovich and Catherine Bulka repeated this in 10,069 NHANES adults aged 40 to 79 with 616 deaths over a mean 58 months. Those below 666 pg/mL had a hazard ratio of 1.31 (95% CI 1.00-1.71, p = .05) against those above 985 pg/mL, falling to 1.24 (95% CI 0.96-1.61, p = .10) in the fully adjusted model [3]. Per 1-SD decrease of 276 pg/mL the association was not significant [3].

What raises it in humans: exercise. Francisco Amaro-Gahete randomised 74 sedentary adults, mean age 53.4 years, to no training, WHO-recommended activity, high-intensity interval training, or interval training plus electromyostimulation for 12 weeks. Every training arm raised soluble Klotho, all P <= 0.019, with no difference between modalities, all P >= 0.696 [5]. No supplement has a comparable randomised result.

The plain takeaway: Klotho loss causes accelerated aging in mice, low levels track with death in humans, and the only reliably documented human lever is training.